Scutellarein Alleviates Ulcerative Colitis by Reshaping Gut Microbiota and Regulating the PRMT1‐Mediated Th17/Treg Balance
Food Frontiers · 2026-07 · 7 (4)
DOI: 10.1002/fft2.70301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food Frontiers, online erschienen am 28.05.2026. Verfasst von Yefan Zhou und 12 weiteren Autor:innen. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: First Affiliated Hospital of Zhengzhou University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Ulcerative colitis (UC) is a chronic inflammatory disease of the colonic mucosa with an increasing global burden and limited therapeutic efficacy. Scutellarein (Scu), a bioactive flavonoid found in various edible plants of Lamiaceae and Verbenaceae , has been shown to possess anti‐inflammatory and antioxidant activities. Herein, we systematically evaluated the effectiveness of scutellarein in the treatment of UC and identified its direct target and underlying inflammation suppression mechanism. Integrated 16S rRNA sequencing and untargeted metabolomics showed that scutellarein preserves gut microbial and metabolic homeostasis and enhances intestinal barrier integrity via enrichment of D‐(‐)‐quinic acid (DQ). Limited proteolysis mass spectrometry (Lip‐MS) identified protein arginine methyltransferase 1 (PRMT1) as a bona fide target of scutellarein. Mechanistic investigations further uncovered that scutellarein directly binds to the Y128 residue of PRMT1, which in turn inhibits STAT3 asymmetric dimethylation and phosphorylation. This cascade collectively downregulates RORγt expression, restrains Th17 differentiation, and ultimately restores the Th17/Treg cell equilibrium. Overall, scutellarein exerts dual protective effects in UC by reinforcing epithelial barrier function through microbiota‐metabolite regulation and suppressing mucosal inflammation via the PRMT1/STAT3/RORγt axis. Our findings not only elucidate a novel multicomponent mechanism for a natural product but also nominate PRMT1 as a compelling new therapeutic target for UC.
Förderung
- First Affiliated Hospital of Zhengzhou University
- National Natural Science Foundation of China
Zitieren
APA
Zhou, Y., Xu, X., Fang, H., Wang, X., Hua, J., Lu, L., Li, D., Wen, Y., Yao, J., Liu, F., He, J., He, F., & Zhou, M. (2026). Scutellarein Alleviates Ulcerative Colitis by Reshaping Gut Microbiota and Regulating the PRMT1‐Mediated Th17/Treg Balance. Food Frontiers, 7(4). https://doi.org/10.1002/fft2.70301
Vancouver
Zhou Y, Xu X, Fang H, Wang X, Hua J, Lu L, et al. Scutellarein Alleviates Ulcerative Colitis by Reshaping Gut Microbiota and Regulating the PRMT1‐Mediated Th17/Treg Balance. Food Frontiers. 2026;7(4). doi:10.1002/fft2.70301
BibTeX
@article{Zhou2026,
author = {Zhou, Yefan and Xu, Xinyu and Fang, Huan and Wang, Xue and Hua, Jiaqi and Lu, Linping and Li, Dongxu and Wen, Yangyang and Yao, Jieqiong and Liu, Fang and He, Jing and He, Fucheng and Zhou, Mingxia},
title = {Scutellarein Alleviates Ulcerative Colitis by Reshaping Gut Microbiota and Regulating the PRMT1‐Mediated Th17/Treg Balance},
journal = {Food Frontiers},
year = {2026},
volume = {7},
number = {4},
doi = {10.1002/fft2.70301}
}
EUVIMED